中国卒中杂志2025，Vol.20Issue(5)：549-554,6.DOI:10.3969/j.issn.1673-5765.2025.05.003
中国卒中临床研究中的溶栓治疗:20年的成就与发展方向
Thrombolytic Therapy in Chinese Stroke Clinical Research:Achievements over the Past Two Decades and Future Directions
摘要
Abstract
In 2002,the results of multicenter RCT of Intravenous Thrombolysis with Urokinase for Acute Cerebral Infarctions were published,marking the beginning of research on thrombolytic drugs for ischemic stroke in China.Subsequently,Chinese researchers in the field of cerebrovascular disease have cautiously learned from international advanced experience,followed the guidance of international guidelines,and continuously standardized and improved thrombolytic therapy for ischemic stroke in China.Today,two decades later,China is capable of independently carrying out innovative research and development.The continuous introduction of new thrombolytic drugs,the continuous breakthroughs in treatment time windows,and the continuous innovation in combination therapy programs have propelled China's stroke thrombolysis research to the forefront of the global stage.China's stroke thrombolytic therapy has undergone two decades of rapid development.This article reviews the transformative journey of thrombolytic therapy in Chinese clinical research on ischemic stroke over the past two decades from the perspective of a participant.关键词
中国/溶栓治疗/急性缺血性卒中Key words
China/Thrombolytic therapy/Acute ischemic stroke分类
医药卫生引用本文复制引用
董漪,董强..中国卒中临床研究中的溶栓治疗:20年的成就与发展方向[J].中国卒中杂志,2025,20(5):549-554,6.基金项目
促进市级医院临床技能与临床创新三年行动计划(2023-2025年)(SHDC2024CRI036) （2023-2025年）
